Beijing snubs reports on China's abuse of Muslim community

Agencies
March 14, 2019

Asia, Mar 14: Rejecting US State Department's report criticising China's abuse of its Uyghur Muslim minorities, Beijing on Thursday said that the said report was full of "ideological prejudice and groundless accusations".

Terming the US Government as a self-styled "human rights defender", China's Foreign Ministry accused the US of pursuing a double standard, reported Xinhua.

In a report called 'Human Rights Record of the United States in 2018', Beijing stated that Washington has a flawed and lacklustre human rights record.

China is in a "league of its own" when it comes to human rights violations, US Secretary of State Michael Pompeo said on Wednesday while criticising Beijing for human rights violations and deterioration of conditions.

Releasing the State Department's annual human rights report titled 'Country Reports on Human Rights Practices', Pompeo alleged that China intensified its crackdown on detaining Muslim minority groups at "record levels".

"There's China, which is in a league of its own when it comes to human rights violations. In just 2018, China intensified its campaign of detaining Muslim minority groups at record levels. Today, more than 1 million Uyghurs, ethnic Kazakhs, and other Muslims are interned in reeducation camps designed to erase their religious and ethnic identities," Pompeo said.

The report highlighted the Chinese government's systematic internment and possible abuse and torture of as many as two million Uyghur Muslims in northwestern Xinjiang Uyghur autonomous region in 2018, South China Morning Post reported.

It slammed China for restricting freedom of speech and allowing or committing violence against religious and ethnic groups.

"Official repression of the freedoms of speech, religion, movement, association, and assembly of Tibetans in the Tibet autonomous region (TAR) and other Tibetan areas and of Uygurs and other ethnic and religious minorities in Xinjiang worsened and was more severe than in other areas of the country," the report said.

The report found that the Chinese government during 2018 "significantly intensified its campaign of mass detention of members of Muslim minority groups in Xinjiang".

It underlined that Chinese authorities "have arbitrarily detained 800,000 to possibly more than two million Uygurs, ethnic Kazakhs, and other Muslims in internment camps designed to erase religious and ethnic identities".

The report also noted China's human rights abuses including unlawful killings by the government, forced disappearance, torture, arbitrary detention, harsh and life-threatening prison and detention conditions, according to South China Morning Post.

"International media, human rights organisations, and former detainees reported security officials in the camps abused, tortured, and killed some detainees," it further noted.

In August last year, a United Nations human rights panel expressed grave concerns that there were credible reports that China was holding a million Uyghur Muslims in mass detention camps in Xinjiang province.

Several international human rights organisations have accused China of cracking down on the Uyghurs by sending them to mass detention camps, interfering in their religious activities and sending the minority community to undergo some form of forceful re-education or indoctrination.

However, Chinese authorities claimed that the camps are "educational training centres", and are needed to clamp down on terrorism and separatist and extremist activities.

Furthermore, the report highlighted that "members of the minority Uyghur ethnic group reported systematic torture and other degrading treatment by law enforcement officers".

The US co-hosted an event with Canada, Germany, the Netherlands, and the United Kingdom at the United Nations in Geneva to raise awareness regarding ongoing and egregious human rights abuses in Xinjiang, where more than one million Uyghurs, ethnic Kazakhs, Kyrgyz, and other members of Muslim minority groups have been detained since April 2017, the State Department said in a release.

"The United States strongly encouraged the UN and the High Commissioner for Human Rights to make these abuses a priority. Government officials, expert panellists, and survivor testimony highlighted the magnitude and severity of the violations of human rights and fundamental freedoms in Xinjiang," it added.

Participants also considered the next steps the international community could take in addressing the situation in Xinjiang, the statement further said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 7,2020

Mar 7: Two Malayalam news channels, Asianet News and Media One, which were banned by the information and broadcasting ministry for their coverage of the recent violence in Delhi on Friday evening, were allowed to resume telecasting on Saturday morning.

While Asianet News appeared to have begun operations around 7am on Saturday, Media One was screening content by 9.30am.

The ministry of information and broadcasting had imposed a 48-hour ban on Asianet News and Media One for their coverage of the Delhi violence for 48 hours from 7.30pm on Friday. Both Asianet News and Media One were barred under Rule 6(1 c) and Rule 6(1e) of the Cable Television Networks Act, 1994.

The ministry of information and broadcasting alleged Asianet News and Media One were "biased" and critical of the RSS and Delhi Police.

The ban on Asianet News and Media One triggered a torrent of criticism of the move. Congress MP Shashi Tharoor asked how "Malayalam channels inflame communal passions in Delhi?" and alleged some English news channels were continuing "their brazen distortions" with impunity.

In a statement issued on Friday after the ban, Media One termed the move "unfortunate and condemnable" and called it a "blatant attack against free and fair reporting". Media One called it "an order to stop free and fair journalism".

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Paris, Jun 29: More than half a million people have been killed by the novel coronavirus, nearly two thirds of them in the United States and Europe, according to an news agency tally at 2200 GMT Sunday based on official sources.

The official death count for the disease now stands at 500,390 deaths from 10,099,576 cases recorded worldwide. The United States has suffered the highest death count (125,747), followed by Brazil (57,622) and the United Kingdom (43,550).

The tallies, using data collected by AFP from national authorities and information from the World Health Organization (WHO), probably reflect only a fraction of the actual number of infections.

Many countries are testing only the most serious cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.